Home / Assets / Emerging Markets (VWO)
Index ETF

The best indicator for Emerging Markets (VWO)

We backtested 20 indicators across daily, weekly and hourly charts on real Emerging Markets (VWO) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.

Trend · Daily

EMA 20/50 Cross

On the daily chart, this is the strongest risk-adjusted edge we found for Emerging Markets (VWO) over ~21.2 years — trailing buy-and-hold by 1.1% CAGR.

5.7%
CAGR
0.44
Sharpe
-35.1%
Max DD
46.9%
Win rate
2.64
Profit factor
-1.1%
vs Buy&Hold
Best by timeframe

The winner on each chart

Daily
EMA 20/50 Cross
-1.1% · Sharpe 0.44
Weekly
Donchian Midline
-1.6% · Sharpe 0.42
Full results

Every indicator, ranked

Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.

#IndicatorTFCAGRSharpeMax DDWinTradesvs B&H
1EMA 20/50 Cross Daily5.7%0.44-35.1%46.9%49-1.1%
2Donchian Midline Weekly5.2%0.42-38.7%40.3%62-1.6%
3ADX / DMI Weekly3.7%0.39-22.3%58.6%29-3.1%
4Rate of Change Weekly4.8%0.39-31.4%56.9%65-2.0%
5MACD Weekly4.6%0.38-31.2%47.5%40-2.2%
6RSI Trend (>50) Weekly4.2%0.35-32.9%37.3%59-2.6%
7Donchian Breakout Weekly3.9%0.34-32.8%47.4%19-2.9%
8EMA-10 Trend Weekly3.6%0.32-48.1%45.0%100-3.2%
9EMA 50/200 Cross Daily4.1%0.32-44.7%35.7%14-2.8%
10SMA 50/200 Cross Daily3.6%0.29-50.8%50.0%16-3.2%
11Donchian BreakoutDaily2.6%0.26-30.9%42.9%98-4.2%
12Bollinger BreakoutWeekly2.1%0.25-30.0%40.9%22-4.6%
13Bollinger Mean-Reversion Weekly2.2%0.22-34.7%68.8%16-4.6%
14Heikin-Ashi Trend Weekly2.2%0.22-32.1%50.5%208-4.6%

= held up out-of-sample. Hypothetical, costs included. See methodology.

What this means

For Emerging Markets (VWO), EMA 20/50 Cross on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.

More index etf

Free · no spam

Get the weekly edge report

The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.